13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001104659-23-021407
Total Value
$630.4M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AXSOME THERAPEUTICS INC | AXSM | 2,011,647 | $155.2M | 24.61% |
| 2 | NUVALENT INC | NUVL | 2,788,981 | $83.1M | 13.18% |
| 3 | VERONA PHARMA PLC | 925050106 | 2,875,526 | $75.1M | 11.92% |
| 4 | BEIGENE LTD | BEIGF | 239,443 | $52.7M | 8.35% |
| 5 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,369,623 | $40.0M | 6.35% |
| 6 | NEUROCRINE BIOSCIENCES INC | NBIX | 283,000 | $33.8M | 5.36% |
| 7 | COGENT BIOSCIENCES INC | COGT | 2,758,975 | $31.9M | 5.06% |
| 8 | BIOCRYST PHARMACEUTICALS INC | BCRX | 2,543,107 | $29.2M | 4.63% |
| 9 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,901,397 | $28.3M | 4.49% |
| 10 | ARGENX SE | ARGX | 73,526 | $27.9M | 4.42% |
| 11 | TERNS PHARMACEUTICALS INC | TERN | 2,040,000 | $20.8M | 3.29% |
| 12 | ANNEXON INC | ANNX | 3,358,563 | $17.4M | 2.75% |
| 13 | TREVI THERAPEUTICS INC | TRVI | 5,696,515 | $11.0M | 1.74% |
| 14 | DBV TECHNOLOGIES SA | DBVTF | 7,064,964 | $10.8M | 1.71% |
| 15 | TYRA BIOSCIENCES INC | TYRA | 1,416,998 | $10.8M | 1.71% |
| 16 | IMARA INC | 45249V107 | 631,333 | $2.6M | 0.41% |